DK1675611T3 - Terapeutiske anvendelser for C-peptid - Google Patents

Terapeutiske anvendelser for C-peptid

Info

Publication number
DK1675611T3
DK1675611T3 DK04768872T DK04768872T DK1675611T3 DK 1675611 T3 DK1675611 T3 DK 1675611T3 DK 04768872 T DK04768872 T DK 04768872T DK 04768872 T DK04768872 T DK 04768872T DK 1675611 T3 DK1675611 T3 DK 1675611T3
Authority
DK
Denmark
Prior art keywords
peptide
therapeutic uses
diabetes
administration
treatment
Prior art date
Application number
DK04768872T
Other languages
English (en)
Inventor
Karin Ekberg
John Wahren
Original Assignee
Creative Peptides Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Peptides Sweden Ab filed Critical Creative Peptides Sweden Ab
Application granted granted Critical
Publication of DK1675611T3 publication Critical patent/DK1675611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK04768872T 2003-10-13 2004-10-13 Terapeutiske anvendelser for C-peptid DK1675611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0323979.5A GB0323979D0 (en) 2003-10-13 2003-10-13 Therapeutic applications for c-peptide
PCT/GB2004/004341 WO2005039627A2 (en) 2003-10-13 2004-10-13 Therapeutic applications for c-peptide

Publications (1)

Publication Number Publication Date
DK1675611T3 true DK1675611T3 (da) 2009-04-06

Family

ID=29559214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04768872T DK1675611T3 (da) 2003-10-13 2004-10-13 Terapeutiske anvendelser for C-peptid

Country Status (12)

Country Link
US (1) US7964558B2 (da)
EP (1) EP1675611B1 (da)
AT (1) ATE416785T1 (da)
AU (1) AU2004283526A1 (da)
CA (1) CA2542172A1 (da)
DE (1) DE602004018352D1 (da)
DK (1) DK1675611T3 (da)
ES (1) ES2319427T3 (da)
GB (1) GB0323979D0 (da)
NZ (1) NZ546912A (da)
PL (1) PL1675611T3 (da)
WO (1) WO2005039627A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2010114049A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Cgrp в качестве терапевтического средства
GB0723250D0 (en) * 2007-11-28 2008-01-09 Univ Leeds Compositions and methods for reducing macrovascular complications in diabetic patients
US8410049B2 (en) * 2009-10-28 2013-04-02 Cebix Methods and kits for preventing hypoglycemia
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
NZ603399A (en) 2010-05-17 2014-09-26 Cebix Inc Pegylated c-peptide
WO2014025127A1 (ko) 2012-08-06 2014-02-13 강원대학교 산학협력단 Ｃ-펩타이드를 포함하는 당뇨성 혈관누출에 의한 질병의 예방 또는 치료용 조성물
RU2522897C1 (ru) * 2013-04-16 2014-07-20 Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" Твердая кишечнорастворимая лекарственная форма с-пептида проинсулина для перорального применения (варианты) и способ ее получения (варианты)
AU2018216033B2 (en) * 2017-02-06 2021-10-07 Biotempt B.V. Peptide modulators of the interaction between human C-peptide and human elastin receptor for therapeutic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH650679A5 (de) 1981-08-27 1985-08-15 Lilly Co Eli Gegen diabetes mellitus wirksames pharmazeutisches mittel.
DE3326473A1 (de) 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
GB0022342D0 (en) 2000-09-12 2000-10-25 Creative Peptides Sweden Ab Reduction of the electrocardiographic QT interval
DE10055857A1 (de) * 2000-11-10 2002-08-22 Creative Peptides Sweden Ab Dj Neue pharmazeutische Depotformulierung
US20020077317A1 (en) 2000-12-15 2002-06-20 Das Undurti Narasimha Method of potentating the action of 2-methoxyoestradiol, statins and C-peptide of proinsulin

Also Published As

Publication number Publication date
GB0323979D0 (en) 2003-11-19
AU2004283526A1 (en) 2005-05-06
CA2542172A1 (en) 2005-05-06
NZ546912A (en) 2009-07-31
EP1675611B1 (en) 2008-12-10
WO2005039627A2 (en) 2005-05-06
US7964558B2 (en) 2011-06-21
WO2005039627A3 (en) 2005-07-28
ATE416785T1 (de) 2008-12-15
PL1675611T3 (pl) 2009-05-29
EP1675611A2 (en) 2006-07-05
ES2319427T3 (es) 2009-05-07
DE602004018352D1 (de) 2009-01-22
US20070082842A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
BRPI0406499A (pt) Insulina de longa atuação para redução da morbidez e mortalidade cardiovascular em pacientes pré-diabéticos e pacientes com diabetes tipo 2
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
BRPI0517701A (pt) uso de um composto na preparação de medicamentos para o tratamento de diabetes mellitus
SI1680128T1 (sl) Mio-inozitol heksafosfat za topično uporabo
MX2009011900A (es) Curacion de herida diabetica.
SE0400184D0 (sv) New therapeutical use
TW200719882A (en) Treatment of connective tissue diseases of the skin
DK1338270T3 (da) Anvendelse af en dihydrochalkon-rig phenolfraktion i en kosmetisk behandling
GB0323979D0 (en) Therapeutic applications for c-peptide
HRP20080146T3 (en) Preoperative treatment of post operative pain
GB0606001D0 (en) Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
CY1116171T1 (el) Χρηση ακετυλο-l-καρνιτινης για την παρασκευη φαρμακου για τη θεραπευτικη αγωγη του νευροπαθητικου πονου σε διαβητικους ασθενεις
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
RU2004105675A (ru) Способ комплексного лечения язв роговицы
BRPI0606350A2 (pt) usos do adapaleno
EA200400478A1 (ru) Способ лечения висцеровертеброгенного болевого синдрома
DE602006002126D1 (de) Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa
PL372345A1 (en) Treatment of type i diabetes mellitus using growth hormone antagonist
UA3958U (uk) Спосіб лікування хронічного гастродуоденіту з супутнім хронічним холециститом
UY28771A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis.